Fundación Sanatorio Güemes

Buenos Aires 1180

0 studies enrolling now · 2 studies all time

What they study most

Covid-19, Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Studies at this site

• CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early